ArticleOncotarget2017

Survival benefit of anti-angiogenic agents in patients with previously treated advanced gastric or gastroesophageal junction cancer: a meta-analysis.

Jung Han Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.